Co-Authors
This is a "connection" page, showing publications co-authored by Annalisa Ruggeri and Giovanni Landoni.
Connection Strength
1.749
-
Trend towards reduction in COVID-19 in-hospital mortality. Lancet Reg Health Eur. 2021 Apr; 3:100059.
Score: 0.233
-
Recent exposure to smoking and COVID-19. Crit Care Resusc. 2020 09; 22(3):253-256.
Score: 0.225
-
Recent exposure to smoking and COVID-19. Crit Care Resusc. 2020 Jul 10.
Score: 0.223
-
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49.
Score: 0.110
-
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis. 2021 06 30; 31(7):2156-2164.
Score: 0.059
-
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front Immunol. 2021; 12:675678.
Score: 0.059
-
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol. 2021 Apr; 3(4):e253-e261.
Score: 0.058
-
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth. 2021 Dec; 35(12):3631-3641.
Score: 0.058
-
Novel Coronavirus Disease (COVID-19) in Italian Patients: Gender Differences in Presentation and Severity. Saudi J Med Med Sci. 2021 Jan-Apr; 9(1):59-62.
Score: 0.057
-
Biobanking for COVID-19 research. Panminerva Med. 2020 Oct 19.
Score: 0.057
-
Integrated clinical role of echocardiography in patients with COVID-19. Heart. 2020 12; 106(23):1864-1865.
Score: 0.057
-
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Sep; 22(3):200-211.
Score: 0.056
-
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart. 2020 09; 106(17):1324-1331.
Score: 0.056
-
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Ann Rheum Dis. 2020 10; 79(10):1277-1285.
Score: 0.056
-
Decreased in-hospital mortality in patients with COVID-19 pneumonia. Pathog Glob Health. 2020 09; 114(6):281-282.
Score: 0.056
-
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e465-e473.
Score: 0.055
-
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol. 2020 08; 217:108509.
Score: 0.055
-
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol. 2020 Jun; 2(6):e325-e331.
Score: 0.055
-
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Apr 23.
Score: 0.055
-
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020 04 15; 22(2):95-97.
Score: 0.055
-
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency Crit Care Resusc. 2020 04 01; 22(2):91-94.
Score: 0.055